EE05054B1 - 5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis - Google Patents

5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis

Info

Publication number: EE05054B1
Authority: EE; Estonia
Prior art keywords: pharmaceutical composition; agonist; antagonist; medicine; oral pharmaceutical
Prior art date: 1998-08-21

Application number

EEP200100104A

Other languages

English (en)

Estonian (et)

Inventor

De Bruijn Karel

Engel G�nter

Pfannkuche Hans-J�rgen

Thewissen Michael

Vitzling Christian

Z�ger Othmar

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-21

Filing date

1999-08-19

Publication date

2008-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27451823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05054(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-21 Priority claimed from GBGB9818340.3A external-priority patent/GB9818340D0/en

1998-10-27 Priority claimed from GBGB9823477.6A external-priority patent/GB9823477D0/en

1999-05-05 Priority claimed from GBGB9910320.2A external-priority patent/GB9910320D0/en

1999-05-12 Priority claimed from GBGB9911059.5A external-priority patent/GB9911059D0/en

1999-08-19 Application filed by Novartis Ag filed Critical Novartis Ag

2002-06-17 Publication of EE200100104A publication Critical patent/EE200100104A/xx

2008-08-15 Publication of EE05054B1 publication Critical patent/EE05054B1/xx

Links

239000003814 drug Substances 0.000 title 1
239000008203 oral pharmaceutical composition Substances 0.000 title 1
239000003523 serotonin 4 antagonist Substances 0.000 title 1
239000000387 serotonin 5-HT4 receptor agonist Substances 0.000 title 1
239000002253 acid Substances 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000012736 aqueous medium Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cosmetics (AREA)
Indole Compounds (AREA)
Peptides Or Proteins (AREA)
Macromonomer-Based Addition Polymer (AREA)

EEP200100104A 1998-08-21 1999-08-19 5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis EE05054B1 (et)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GBGB9818340.3A GB9818340D0 (en)	1998-08-21	1998-08-21	Organic compounds
GBGB9823477.6A GB9823477D0 (en)	1998-10-27	1998-10-27	Organic compounds
GBGB9910320.2A GB9910320D0 (en)	1999-05-05	1999-05-05	Organic compounds
GBGB9911059.5A GB9911059D0 (en)	1999-05-12	1999-05-12	Organic compounds
PCT/EP1999/006083 WO2000010526A2 (en)	1998-08-21	1999-08-19	New oral formulation for 5-ht4 agonists or antagonists

Publications (2)

Publication Number	Publication Date
EE200100104A EE200100104A (et)	2002-06-17
EE05054B1 true EE05054B1 (et)	2008-08-15

Family

ID=27451823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100104A EE05054B1 (et)	1998-08-21	1999-08-19	5-HT4 agonisti v?i antagonisti peroraalne ravimkoostis ja selle kasutamine meditsiinis

Country Status (29)

Country	Link
US (4)	US20030236183A1 (sr)
EP (1)	EP1104289B1 (sr)
JP (1)	JP4048024B2 (sr)
KR (1)	KR100529659B1 (sr)
CN (2)	CN1165293C (sr)
AT (1)	ATE316782T1 (sr)
AU (4)	AU762829B2 (sr)
BG (1)	BG65322B1 (sr)
BR (1)	BR9913135A (sr)
CA (1)	CA2338794C (sr)
CZ (1)	CZ300647B6 (sr)
DE (1)	DE69929703T2 (sr)
DK (1)	DK1104289T3 (sr)
EE (1)	EE05054B1 (sr)
ES (1)	ES2257869T3 (sr)
FR (3)	FR2782454B1 (sr)
HR (1)	HRP20010123B1 (sr)
HU (1)	HU228179B1 (sr)
ID (1)	ID28510A (sr)
IL (1)	IL141236A0 (sr)
IS (1)	IS2369B (sr)
IT (1)	IT1314185B1 (sr)
NO (1)	NO328756B1 (sr)
NZ (1)	NZ509832A (sr)
PL (2)	PL200132B1 (sr)
RS (1)	RS50104B (sr)
SK (1)	SK285255B6 (sr)
TR (3)	TR200100361T2 (sr)
WO (1)	WO2000010526A2 (sr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001270304A1 (en)	2000-07-07	2002-01-21	The Administrators Of The Tulane Educational Fund	Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
AU2002231627A1 (en) *	2000-11-24	2002-06-03	Janssen Pharmaceutica N.V.	Use of a triple combination comprising a 5HT3 antagonist, a 5HT4 agonist and a laxative for promoting intestinal lavage
EP1321142A1 (en) *	2001-12-21	2003-06-25	Novartis AG	Solid pharmaceutical composition for oral administration of Tegaserod
CA2517310C (en) *	2003-02-28	2015-11-24	Chugai Seiyaku Kabushiki Kaisha	Stabilized protein-containing formulations comprising a poloxamer
AU2003222439A1 (en) *	2003-03-25	2004-10-18	Hetero Drugs Limited	Novel crystalline forms of tegaserod maleate
GB0307440D0 (en) *	2003-03-31	2003-05-07	Novartis Ag	Organic compounds
MY137386A (en) *	2003-07-24	2009-01-30	Novartis Ag	Stable modifications of tegaserod hydrogen maleate
US8591972B2 (en)	2005-05-23	2013-11-26	Kraft Foods Global Brands Llc	Delivery system for coated active components as part of an edible composition
US8591974B2 (en)	2003-11-21	2013-11-26	Kraft Foods Global Brands Llc	Delivery system for two or more active components as part of an edible composition
US8591968B2 (en)	2005-05-23	2013-11-26	Kraft Foods Global Brands Llc	Edible composition including a delivery system for active components
US20050112236A1 (en)	2003-11-21	2005-05-26	Navroz Boghani	Delivery system for active components as part of an edible composition having preselected tensile strength
US8591973B2 (en)	2005-05-23	2013-11-26	Kraft Foods Global Brands Llc	Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US8597703B2 (en)	2005-05-23	2013-12-03	Kraft Foods Global Brands Llc	Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
US8389032B2 (en)	2005-05-23	2013-03-05	Kraft Foods Global Brands Llc	Delivery system for active components as part of an edible composition having selected particle size
US8216610B2 (en)	2004-05-28	2012-07-10	Imaginot Pty Ltd.	Oral paracetamol formulations
CA2629904C (en)	2005-11-28	2018-07-10	Imaginot Pty Ltd.	Oral therapeutic compound delivery system
US12186426B2 (en)	2009-10-30	2025-01-07	Ix Biopharma Ltd.	Solid dosage form
TR201902233T4 (tr)	2009-10-30	2019-03-21	Ix Biopharma Ltd	Hızlı çözünen katı dozaj formu.
US20140296831A1 (en)	2011-08-20	2014-10-02	Fred Göbel	Trans-anal inflow catheter and method for intermittently triggering a reflex-coordinated defecation
UA118339C2 (uk) *	2012-09-03	2019-01-10	Біогайа Аб	Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US552398A (en) *		1895-12-31		Riveting-machine
JP2708803B2 (ja) *	1987-09-02	1998-02-04	中外製薬株式会社	持続放出製剤
DK0472502T3 (da) *	1990-08-24	1995-10-09	Spirig Ag	Fremgangsmåde til fremstilling af pellets
HUT64023A (en) *	1991-03-22	1993-11-29	Sandoz Ag	Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
US5523289A (en) *	1991-04-15	1996-06-04	Abbott Laboratories	Pharmaceutical composition
US20020128172A1 (en) *	1991-12-21	2002-09-12	Smithkline Beecham Plc	Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
FR2710915B1 (fr) *	1993-10-04	1995-11-24	Synthelabo	Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.
TW270114B (sr) *	1993-10-22	1996-02-11	Hoffmann La Roche
US5399562A (en) *	1994-02-04	1995-03-21	G. D. Searle & Co.	Indolones useful as serotonergic agents
JPH0820586A (ja) *	1994-07-05	1996-01-23	Sanwa Kagaku Kenkyusho Co Ltd	１−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
EP0804169A4 (en) *	1994-12-01	1998-08-19	Cibus Pharmaceutical Inc	NSAID ADMINISTRATION USING A POWDERED HYDROCOLLOID GUM MACHINABLE FROM HIGHER PLANTS
US5654320A (en) *	1995-03-16	1997-08-05	Eli Lilly And Company	Indazolecarboxamides
IL117438A (en) *	1995-03-16	2001-12-23	Lilly Co Eli	Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
JPH09194374A (ja) *	1995-11-14	1997-07-29	Taisho Pharmaceut Co Ltd	消化器疾患治療剤
US5705190A (en) *	1995-12-19	1998-01-06	Abbott Laboratories	Controlled release formulation for poorly soluble basic drugs
US5739151A (en) *	1996-07-19	1998-04-14	Sepracor Inc.	Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
FR2753196B1 (fr) *	1996-09-12	1998-10-23	Synthelabo	Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
BR9813808A (pt) *	1997-12-19	2002-05-28	Smithkline Beecham Corp	Processo para produção de comprimidos para dispersão na mordida
US20010014352A1 (en) *	1998-05-27	2001-08-16	Udit Batra	Compressed tablet formulation
EP1321142A1 (en) *	2001-12-21	2003-06-25	Novartis AG	Solid pharmaceutical composition for oral administration of Tegaserod

1999
- 1999-08-19 ES ES99942892T patent/ES2257869T3/es not_active Expired - Lifetime
- 1999-08-19 DE DE69929703T patent/DE69929703T2/de not_active Expired - Lifetime
- 1999-08-19 DK DK99942892T patent/DK1104289T3/da active
- 1999-08-19 TR TR2001/00361T patent/TR200100361T2/xx unknown
- 1999-08-19 SK SK243-2001A patent/SK285255B6/sk not_active IP Right Cessation
- 1999-08-19 BR BR9913135-8A patent/BR9913135A/pt not_active Application Discontinuation
- 1999-08-19 EP EP99942892A patent/EP1104289B1/en not_active Expired - Lifetime
- 1999-08-19 CN CNB998099244A patent/CN1165293C/zh not_active Expired - Lifetime
- 1999-08-19 TR TR2001/02259T patent/TR200102259T2/xx unknown
- 1999-08-19 CN CNA2004100638733A patent/CN1589906A/zh active Pending
- 1999-08-19 IT IT1999MI001826A patent/IT1314185B1/it active
- 1999-08-19 JP JP2000565848A patent/JP4048024B2/ja not_active Expired - Lifetime
- 1999-08-19 NZ NZ509832A patent/NZ509832A/en not_active IP Right Cessation
- 1999-08-19 RS YUP-87/01A patent/RS50104B/sr unknown
- 1999-08-19 PL PL380173A patent/PL200132B1/pl unknown
- 1999-08-19 HU HU0103431A patent/HU228179B1/hu unknown
- 1999-08-19 KR KR10-2001-7002161A patent/KR100529659B1/ko not_active Expired - Lifetime
- 1999-08-19 AU AU56232/99A patent/AU762829B2/en not_active Expired
- 1999-08-19 WO PCT/EP1999/006083 patent/WO2000010526A2/en not_active Ceased
- 1999-08-19 AT AT99942892T patent/ATE316782T1/de active
- 1999-08-19 HR HR20010123A patent/HRP20010123B1/xx not_active IP Right Cessation
- 1999-08-19 EE EEP200100104A patent/EE05054B1/xx unknown
- 1999-08-19 TR TR2004/00187T patent/TR200400187T2/xx unknown
- 1999-08-19 CA CA002338794A patent/CA2338794C/en not_active Expired - Lifetime
- 1999-08-19 IL IL14123699A patent/IL141236A0/xx not_active IP Right Cessation
- 1999-08-19 CZ CZ20010619A patent/CZ300647B6/cs not_active IP Right Cessation
- 1999-08-19 PL PL99346764A patent/PL194069B1/pl unknown
- 1999-08-19 ID IDW20010318A patent/ID28510A/id unknown
- 1999-08-20 FR FR9910666A patent/FR2782454B1/fr not_active Expired - Lifetime
- 1999-11-26 FR FR9914897A patent/FR2784899B1/fr not_active Expired - Lifetime
2000
- 2000-02-20 IS IS5851A patent/IS2369B/is unknown
- 2000-08-21 FR FR0010748A patent/FR2799123B1/fr not_active Expired - Lifetime
2001
- 2001-02-14 BG BG105257A patent/BG65322B1/bg unknown
- 2001-02-20 NO NO20010863A patent/NO328756B1/no not_active IP Right Cessation
2003
- 2003-07-15 US US10/620,178 patent/US20030236183A1/en not_active Abandoned
- 2003-09-22 AU AU2003248212A patent/AU2003248212A1/en not_active Abandoned
2006
- 2006-01-06 AU AU2006200048A patent/AU2006200048A1/en not_active Abandoned
2007
- 2007-11-29 US US11/947,769 patent/US20080075773A1/en not_active Abandoned
2009
- 2009-02-04 AU AU2009200403A patent/AU2009200403A1/en not_active Abandoned
2011
- 2011-11-23 US US13/303,459 patent/US20120071537A1/en not_active Abandoned
2013
- 2013-01-31 US US13/755,444 patent/US20130158092A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO20010863D0 (no)	2001-02-20
JP4048024B2 (ja)	2008-02-13
US20120071537A1 (en)	2012-03-22
IT1314185B1 (it)	2002-12-06
ID28510A (id)	2001-05-31
BG105257A (en)	2001-11-30
AU2003248212A1 (en)	2003-10-30
CZ2001619A3 (en)	2001-05-16
KR100529659B1 (ko)	2005-11-21
EP1104289B1 (en)	2006-02-01
NO20010863L (no)	2001-03-26
NO328756B1 (no)	2010-05-03
AU762829B2 (en)	2003-07-03
SK2432001A3 (en)	2001-09-11
DK1104289T3 (da)	2006-05-15
FR2799123B1 (fr)	2005-12-02
DE69929703T2 (de)	2007-02-22
ITMI991826A0 (it)	1999-08-19
RS50104B (sr)	2009-01-22
FR2784899B1 (fr)	2001-08-17
CN1165293C (zh)	2004-09-08
CA2338794C (en)	2009-01-20
PL346764A1 (en)	2002-02-25
IS2369B (is)	2008-06-15
SK285255B6 (sk)	2006-09-07
IL141236A0 (en)	2002-03-10
HRP20010123A2 (en)	2002-02-28
BG65322B1 (bg)	2008-02-29
CN1323200A (zh)	2001-11-21
US20130158092A1 (en)	2013-06-20
KR20010079668A (ko)	2001-08-22
PL200132B1 (pl)	2008-12-31
PL194069B1 (pl)	2007-04-30
FR2799123A1 (fr)	2001-04-06
TR200102259T2 (tr)	2002-06-21
ES2257869T3 (es)	2006-08-01
TR200100361T2 (tr)	2001-06-21
EE200100104A (et)	2002-06-17
DE69929703D1 (de)	2006-04-13
JP2002523351A (ja)	2002-07-30
EP1104289A2 (en)	2001-06-06
US20080075773A1 (en)	2008-03-27
US20030236183A1 (en)	2003-12-25
AU2006200048A1 (en)	2006-02-02
AU5623299A (en)	2000-03-14
HUP0103431A3 (en)	2002-02-28
HUP0103431A2 (hu)	2002-01-28
HK1038179A1 (en)	2002-03-08
IS5851A (is)	2001-01-20
FR2784899A1 (fr)	2000-04-28
YU8701A (sh)	2003-12-31
ATE316782T1 (de)	2006-02-15
HU228179B1 (en)	2013-01-28
ITMI991826A1 (it)	2001-02-19
CA2338794A1 (en)	2000-03-02
CZ300647B6 (cs)	2009-07-08
FR2782454A1 (fr)	2000-02-25
WO2000010526A2 (en)	2000-03-02
AU2009200403A1 (en)	2009-02-26
WO2000010526A3 (en)	2000-09-08
NZ509832A (en)	2003-11-28
BR9913135A (pt)	2001-05-08
TR200400187T2 (tr)	2006-11-21
CN1589906A (zh)	2005-03-09
FR2782454B1 (fr)	2005-12-02
HRP20010123B1 (hr)	2010-11-30

Legal Events

Date	Code	Title	Description
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231

Publication	Publication Date	Title
EE200100104A (et)	2002-06-17	5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
TR200001942T2 (tr)	2000-11-21	Opioid agonist/antagonist kombinasyonlar
BR0107147A (pt)	2002-06-18	Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações
CY1111698T1 (el)	2015-10-07	Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
CY1110906T1 (el)	2015-06-10	Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
BR9810495A (pt)	2000-09-12	Composição farmacêutica
DE50005529D1 (de)	2004-04-08	Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
TR199800631A2 (xx)	1998-10-21	Ecza form�lasyonu.
TR200401793T4 (tr)	2004-08-23	Perindopril tuzu ve bunu içeren farmasötik bileşimler.
BR0206960A (pt)	2004-03-09	Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE59914183D1 (de)	2007-03-22	Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
IS5390A (is)	2000-02-29	Bensoxazín og bensóþíazín afleiður og notkun þeirra í lyf
HRP20050342B1 (hr)	2013-11-08	Farmaceutska formulacija olanzapina
MXPA01011842A (es)	2003-09-04	Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
YU87501A (sh)	2004-05-12	Farmaceutski kompleksi
TR200003451T2 (tr)	2001-04-20	Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
ATE286395T1 (de)	2005-01-15	Antithrombotische mittel
NO20004816L (no)	2000-11-02	Ny farmasøytisk formulering
BR0016235A (pt)	2002-08-27	Derivados heterocìclicos
MY128958A (en)	2007-03-30	New oral formulation for 5-ht4 agonists or antagonists.
ECSP993104A (es)	1999-10-06	Nueva formulacion oral
CR6300A (es)	2004-06-08	Nueva formulacion oral